* Novel treatment shows promise against rare cancer in kids The Associated Press
* New type of genetically-engineered T-cell may destroy solid cancer tumors New Atlas
* GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma | NEJM nejm.org
* Clinical trial may change the paradigm of care for patients with ALK-driven high-risk neuroblastoma News-Medical.Net
* ‘Supercharged’ cancer treatment shows promise against rare strain New Zealand Herald
* View Full Coverage on Google News
http://dlvr.it/Sm4kLB